Hematopoietic Neoplasm/Leukemia - Chronic Lymphoid Leukemia
NCT02048813
Clinical Trial Information
Trial Number: NCT02048813 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Chronic Lymphoid Leukemia
Trial Title:
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)
Study ID:
E1912
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02048813-D3 | There are three different submissions (each with one dataset) for PMID 31365801 from ECOG-ACRIN trial E1912. This dataset NCT02048813-D3 contains toxicity data as shown in supplemental Table S7 of the paper. Dataset NCT02048813-D1 contains baseline, treatment, and efficacy data. Dataset, NCT02048813-D2, contains toxicity data as shown in Table 2 of the paper. |
| NCT02048813-D2 | There are three different submissions (each with one dataset) for PMID 31365801 from ECOG-ACRIN trial E1912. This dataset, NCT02048813-D2, contains toxicity data as shown in Table 2 of the paper. Dataset NCT02048813-D1 contains baseline, treatment, and efficacy data. Dataset NCT02048813-D3 contains toxicity data as shown in supplemental Table S7 of the paper. |
| NCT02048813-D1 | There are three different submissions (each with one dataset) for PMID 31365801 from ECOG-ACRIN trial E1912. This dataset, NCT02048813-D1, contains baseline, treatment, and efficacy data. Dataset NCT02048813-D2 contains toxicity data as shown in Table 2 of the paper. Dataset NCT02048813-D3 contains toxicity data as shown in supplemental Table S7 of the paper. |
NCT01886872
Clinical Trial Information
Trial Number: NCT01886872 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Chronic Lymphoid Leukemia
Trial Title:
A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (>=65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Study ID:
A041202
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01886872-D5 | Dataset NCT01886872-D5-Dataset.csv (bsl_qol) is one of 5 datasets associated with PubMed ID 30501481. This dataset contains information that will allow you to reproduce the baseline QOL analysis (table S3) in the supplemental materials. |
| NCT01886872-D4 | Dataset Name: NCT01886872-D4-Dataset.csv (Deaths) Description: This dataset contains one observation for each patient death. The cause of death was characterized by the Study Chair by taking into account the following: Grade 5 adverse events, contributing adverse events, cause of death reported, and correspondence between the study team and site. |
| NCT01886872-D3 | Dataset Name: NCT01886872-D3-Dataset.csv (PreRegistration) Description: This dataset contains one observation per patient screened, but not enrolled to A041202. |
| NCT01886872-D2 | NCT01886872-D2-Dataset.csv is one of 5 datasets needed to reproduce the Pubmed ID 30501481. This dataset contains will allow you to reproduce the adverse events analysis reported in the manuscript. There are multiple observations in this dataset for each patient. For each patient, there is one observation per adverse event per cycle. All adverse events are included (treatment, observation, late, crossover). |
| NCT01886872-D1 | NCT01886872-D1-Dataset.csv (Analysis) Description: This dataset is a collection of data used for analysis of primary and secondary objectives. Contains one observation per patient enrolled to A041202. It does not contain Adverse Event data nor patients that were screened and pre-registered to A041202 but never enrolled. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®